Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT06957314

A Study of Hospital-at-Home for People Receiving Tarlatamab

Conditions: Small-cell Lung Cancer, Small Cell Lung Carcinoma

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: NA

Enrollment: 70

Sponsor: Memorial Sloan Kettering Cancer Center

Location: Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge New Jersey

Summary

The purpose of this study is to find out whether a Hospital-at-Home (HaH) program is a more efficient way to monitor people's health after receiving tarlatamab than monitoring in the hospital (inpatient).

Eligibility Criteria

Inclusion Criteria: Patient * Diagnosis of extensive stage small cell lung carcinoma (ES-SCLC) * Treatment plan of commercially available tarlatamab monotherapy as standard of care * Patients must be 18 years of age or older * Eastern Cooperative Oncology Group (ECOG) performance status \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06957314). StuddyBuddy aggregates publicly available trial information.